A generator is used in nuclear medicine to provide a radioisotope used for a scintigraphic procedure. A generator contains a radionuclide (e.g. molybdenum) that decays to another radionuclide (decay product, e.g. technetium) that can be extracted and used. The original radionuclide is firmly bound in the generator and remains behind.

See also Eluate

Lifetime is the mean life of a particle or in case of a radioactive nucleus equal to its decay time.

See also Half-Life, Decay.

(NAA) Neutron activation analysis is a very sensitive analytical technique to determine even very low concentration of chemical elements, trace elements for example, in small biological samples.
NAA becomes commercial available in the USA in 1960.
In the activation process stable nuclides in the sample, which is placed in a neutron beam (neutron flux, 90-95% are thermal neutron with low energy levels under 0.5 eV), will change to radioactive nuclides through neutron capture (artificial radioactivity). These radioactive nuclides decay by emitting alpha-, beta-particles and gamma-rays with a unique half-life. Qualitative and quantitative analysis of the sample is done with a high-resolution gamma-ray spectrometer.
NAA is subdivided into the following techniques:

Radionuclides are naturally occurring or artificially produced atoms with unstable nuclei. Therefore radionuclides undergo a radioactive decay, and emit gamma ray(s) and/or subatomic particles.
Radionuclides are used as agents in nuclear medicine and to destroy tumors in cancer therapy.

See Isotope and Radioactive Decay.

Activation is the production of radionuclides (instable atoms) by bombarding atomic nuclei (stable atoms) with radiation (e.g., photons, neutrons, alpha particles).
With the activation of an atom its decay starts.

See Neutron Activation, Neutron Activation Analysis.